Nectar Lifesciences Limited
Share Price Target & Analysis

NSE:NECLIFE

10.66

VWAP

11.08

Open

10.76

Close

11.08

High

10.23

Low

22.4

52 Week High

10.28 ⇩
-0.48 (-4.46%)

NECLIFE

(PHARMA)
7.5% Momentum

Watch Carefully

9.3

52 Week Low

-13.38

EPS

-0.95

PE

0.4

PB

Uncertain
Quality

Unclear
Valuation

#Analysis

NSE: NECLIFE Share Price Financial Analysis & Valuation

Nectar Lifesciences Limited (NECLIFE) is broadly categorized in PHARMA segment industry which deals in Pharmaceuticals vertical. It is one of SME Stocks company with Market Capitalization of Rs 734.5 (in Cr). Total number of free float shares are 22.4 (in Lacs). Nectar Lifesciences Limited is listed on NSE with Exchange ID - INE023H01027 and trading code is NSE:NECLIFE with short name Nectar Life.

In the past 1 year, Nectar Lifesciences Limited has declared an equity dividend of Rs 0 per share. At the current share price of NECLIFE at Rs 10.28, this results in a dividend yield of 0 %.

As per the Fundamental Analysis of NSE:NECLIFE, which uses revenues, earnings, future growth, financial ratios, return on equity, profit margins, and other data to determine NECLIFE underlying value and future prospects. All of this data is available in NECLIFE financial statements.

Quality of the Stock: As per the fundamental analysis of NSE:NECLIFE, it is clearly understood that NECLIFE is Uncertain performer in terms of earnings and profit margins with an EPS of -13.38. NSE:NECLIFE book value per share as of today is 25.51. The current price to book ratio for NECLIFE as of Oct 24, 2026 is 0.4.

Valuation of the Stock: The current valuation of NECLIFE stock is like Unclear which means currently the stock is Confusing. Now, it's totally depends upon the risk appetite of an investor and risk-reward ratio of NECLIFE whether to BUY this stock at current valuation. The delivery percentage of NECLIFE is 189670% is very crucial parameter which shows that 189670% investors are anticipating that the price of NECLIFE share should go up with VWAP at 10.66.

Now, the main question is whether to BUY or SELL, NSE:NECLIFE at current valuation.
As per latest Analysis No. #3275:-

⇑ STRONG BUY NECLIFE if All Greens

⇗ BUY NECLIFE (at Lower Levels) if any 2 Greens

⇒ NEUTRAL or HOLD NECLIFE (With Stop Loss) if only 1 Green

⇘ SELL NECLIFE if NO Green Indicator

NSE: NECLIFE Share Price Today (Oct 24, 2026)

(Nectar Lifesciences Limited Daily Analysis on the basis of NECLIFE Intraday Graph & Trend)

Nectar Lifesciences Limited share price moved Down by -4.46% from its previous close of Rs 10.76. NECLIFE stock last traded price is 10.28. NECLIFE share price trend is Down with a total of 101721 stocks traded till now. It has touched an intraday high of Rs 11.08 and an intraday low of Rs 10.23. The NECLIFE trading at 10.28, Down by Rs. -0.48, or -4.46 percent which suggests that most of the Traders are anticipating that the price of NECLIFE share should go Down.

NSE: NECLIFE Share Price Tomorrow Prediction

(Nectar Lifesciences Limited Share Price Prediction for Tomorrow & future forecast is based on Current Trend of NECLIFE)

Nectar Lifesciences Limited share price moved Down by -4.46%. NECLIFE share price short term trend is Down. It suggests that NECLIFE Share Price for Tomorrow remains the same with VWAP at 10.66 will be treated as stop loss for intraday traders. Nectar Lifesciences Limited Long term investors can follow the NECLIFE long term trend as mentiond in future forecast table.

NSE Code

NSE: NECLIFE

NECLIFE Share Price Today

 10.28

NECLIFE Share Price Target Prediction for 2026 ^

 9.8 - 16.9

NECLIFE Share Price Target Prediction for 2027*^

 16.9 - 17.6

NECLIFE Share Price Target Prediction for 2028*^

 17.6 - 18.5

NECLIFE Share Price Target Prediction for 2029*^

 19

NECLIFE Share Price Target Prediction for 2030*^

 20

NECLIFE Share Price Target Prediction for 2035*^

 21
NECLIFE Current Book Value
25.4

*Nectar Lifesciences Limited Short Term & Long Term share price target is based on current financial year earings of the company.
^NECLIFE share price target prediction for 2026 2027 2028 2029 2030 to 2035 is based on current market scenario, future forecast & growth assumptions, they might change subject to market sentiments.

NECLIFE Technical Analysis

Candlestick Pattern: @11.98

NECLIFE Moving Averages

BUY (9) NEUTRAL (0) SELL (5)
MA Simple Action S1 Expo Action E2
MA_5 12.11 SELL 12.1 SELL
MA_12 12.12 SELL 11.95 BUY
MA_20 11.66 BUY 11.76 BUY
MA_32 11.17 BUY 11.53 BUY
MA_50 11.14 BUY 11.47 BUY
MA_100 11.58 BUY 11.66 BUY
MA_200 13.26 SELL 13.48 SELL

NECLIFE Trend Oscillators

BUY (2) NEUTRAL (1) SELL (1)
Trend Oscillators Value Action
Bollinger Bands 11.66 Uptrend
MACD 0.01 BUY
ADX 17.49 NO or Weak Trend
DMI (+/-) 21.63 / 21.79 Downtrend

NECLIFE Momentum Oscillators

BUY (4) NEUTRAL (5) SELL (3)
Momentum Oscillators Value Action
RSI 55.47 Neutral
STOCHASTIC_K (Fast) 19.81 Oversold
STOCHASTIC_D (Slow) 34.28 Neutral
CCI 9.06 Neutral
PSAR 11.14 BUY
TRUE RANGE 0.46 BUY
ATR 0.58 BUY
WILLIAMS R -44.06 Neutral
TRIX 0 Neutral
STOCHASTIC RSI K 0 Oversold
STOCHASTIC RSI D 8.6 Oversold
MOMENTUM 1.48 BUY

NECLIFE Last 1 Year Trend

Duration Value
1 Year -18.28%
3 Months 1.27%
1 Month 14.1%
1 Week -2.68%

NECLIFE Technical Analysis Summary

Updated on 2026-09-09
Action Overall (%)
BUY 50%
NEUTRAL / HOLD 20%
SELL 30%

(powered by Zerodha)

Most popular Questions & Answers about NECLIFE

Nectar Lifesciences Limited Frequently Asked Questions (FAQs)

Nectar Lifesciences Limited stock last traded price is 10.28. NECLIFE share price moved Down by -4.46% from its previous close of Rs 10.76.

Nectar Lifesciences Limited share price trend is Down with a total of 101721 stocks traded till now. It has touched an intraday high of Rs 22.624 and an intraday low of Rs 10.23. The NECLIFE trading at 10.28, Down by Rs. -0.48, or -4.46 percent which suggests that most of the Traders are anticipating that the price of NECLIFE share should go Down and the Stop Loss will be around 10.66.

The market cap of Nectar Lifesciences Limited is ₹734.5 (in Cr) as of Oct 23, 2026.

The current price to earning ratio for Nectar Lifesciences Limited as of Oct 23, 2026 is -0.95.

The current price to book ratio for Nectar Lifesciences Limited as of Oct 23, 2026 is 0.4.

The highest price of Nectar Lifesciences Limited stock is ₹22.4 in the last 52-week.

The lowest price of Nectar Lifesciences Limited stock is ₹9.3 in the last 52-week.

Nectar Lifesciences Limited share trading at ₹10.28, Down by Rs. -0.48, or -4.46 percent which suggests that most of the traders are anticipating that the price of NECLIFE share should go Down.

In 2026, Stock price target for Nectar Lifesciences Limited (NECLIFE) will be around ₹9.8 on downside and ₹16.9 on upside. Nectar Lifesciences Limited share price target is based on current financial year earings of the company.

In 2027, Stock price target for Nectar Lifesciences Limited (NECLIFE) will be around ₹16.9 on downside and ₹17.6 on upside. Nectar Lifesciences Limited share price target is based on forecasted future earnings of the company.

In 2028, Stock price target for Nectar Lifesciences Limited (NECLIFE) will be around ₹17.6 on downside and ₹18.5 on upside. Nectar Lifesciences Limited share price target is based on Discounted Cash Flow (DCF) method uses the projected future cash flows of the business.

In next five years, Stock price target for Nectar Lifesciences Limited (NECLIFE) will be around ₹20 Nectar Lifesciences Limited share price target is based on market scenario & growth assumptions, they might change subject to market sentiments and forecasted future earnings of NECLIFE.

The price of Nectar Lifesciences Limited (NECLIFE) shares moved by -4.46%. The short-term trend for NECLIFE share price is Down. It implies that the share price of NECLIFE will stay the same tomorrow and that intraday traders should treat VWAP at 10.66 as a stop loss. Investors with a long-term outlook can track NECLIFE long-term trajectory, which is indicated in the future forecast table.

Estimated DCF Value of NECLIFE stock is Unavailable at this moment. Compared to the current market price of 10.28 INR, the NECLIFE stock is unpredictable by lack of Insufficient data.

As per the fundamental analysis of Nectar Lifesciences Limited (NECLIFE), it is of Uncertain quality in terms of earnings and profit margins with an EPS of 0. Nectar Lifesciences Limited book value per share as of today is 25.51. The current price to book ratio for NECLIFE as of Oct 24, 2026 is 0.4.


NSE:NECLIFE News & Other Useful Information about NECLIFE Share Price


Peer Comparison of NSE: NECLIFE

The Peers list includes companies operating in the same industry and having comparable market cap.

Sector: Pharmaceuticals

Company Price EPS BV
SUNPHARMA 1748.00 16.35 97.89
DIVISLAB 8950.00 115.55 663.06
MEDICAMEQ 253.35 12.15 208.08
CIPLA 1338.00 51.67 434.02
DRREDDY 1229.50 53.19 380.63
TORNTPHARM 4524.40 87.32 235.7
BIOCON 323.50 1.27 166.51
LUPIN 1928.90 154.86 718.33
ALKEM 4947.00 212.33 1218.48
AUROPHARMA 1571.70 46.49 403.84
ABBOTINDIA 25030.00 766.11 2448.41
GLAXO 2404.70 63.65 147.25
IPCALAB 1953.30 56.72 329.23
LAURUSLABS 1970.00 20.74 102.57
LALPATHLAB 1838.20 39.68 157.23
PFIZER 3612.30 170.54 963.41
AJANTPHARM 3283.90 89.3 363.23
SANOFI 2772.80 158.05 332.96
NATCOPHARM 791.85 82.14 505
APLLTD 760.10 48.4 295.69
JBCHEPHARM 2408.90 54.16 251.48
GLENMARK 2166.60 1.24 881.78
AAREYDRUGS 106.73 2.39 53.38
JUBLPHARMA 938.30 4.35 145.63
SPARC 171.77 48.14 40.45
GRANULES 794.75 23.25 180.42
ASTRAZEN 5988.50 86.44 364.29
CAPLIPOINT 2222.00 55.52 285.6
FDC 338.70 21.19 161.21
HIKAL 193.65 9.34 96.63
Updated at: 2026-10-23 15:57:22

Feel free to contact us, in case of any queries.

Disclaimer: Published information or data available on the Website may not be current or up to date and also any information or data available on this website may contain inaccuracies and/or typographical errors. Kindly refer any reliable source for its accuracy. If you select any of these stocks for your trades, you do so at your own risk.

Stocks to Watch Today

ADANIENT 2477.00 -73.00 (-2.86%) | ADANIPORTS 1702.70 -47.30 (-2.7%) | APOLLOHOSP 7730.00 125.50 (1.65%) | ASIANPAINT 2307.00 22.20 (0.97%) | AXISBANK 1217.50 5.50 (0.45%) | BAJAJ-AUTO 10072.00 -83.00 (-0.82%) | BAJAJFINSV 1655.00 -23.00 (-1.37%) | BAJFINANCE 928.95 -13.15 (-1.4%) | BEL 362.00 -2.50 (-0.69%) | BHARTIARTL 1892.10 -2.90 (-0.15%) | CIPLA 1338.00 7.10 (0.53%) | COALINDIA 397.45 -5.10 (-1.27%) | DRREDDY 1229.50 -9.50 (-0.77%) | EICHERMOT 7066.00 -18.50 (-0.26%) | GRASIM 2894.00 -0.40 (-0.01%) | HCLTECH 1422.20 0.50 (0.04%) | HDFCBANK 692.80 -1.25 (-0.18%) | HDFCLIFE 523.75 -4.60 (-0.87%) | HINDALCO 869.85 -15.75 (-1.78%) | HINDUNILVR 1814.70 -13.60 (-0.74%) | ICICIBANK 1394.20 -4.30 (-0.31%) | INDIGO 4549.00 -51.00 (-1.11%) | INFY 1153.80 0.45 (0.04%) | ITC 257.90 -1.00 (-0.39%) | JIOFIN 205.03 -5.77 (-2.74%) | JSWSTEEL 1185.50 -34.50 (-2.83%) | KOTAKBANK 430.50 -6.50 (-1.49%) | LT 3647.00 8.70 (0.24%) | M&M 2861.20 -2.90 (-0.1%) | MARUTI 11230.00 60.00 (0.54%) | MAXHEALTH 815.00 -2.00 (-0.24%) | NESTLEIND 1175.00 -14.90 (-1.25%) | NTPC 298.00 -4.60 (-1.52%) | ONGC 227.50 2.50 (1.11%) | POWERGRID 247.40 -1.00 (-0.4%) | RELIANCE 1190.00 5.50 (0.46%) | SBILIFE 1640.00 -2.90 (-0.18%) | SBIN 958.60 -11.40 (-1.18%) | SUNPHARMA 1748.00 -10.00 (-0.57%) | TATACONSUM 963.90 4.10 (0.43%) | TATASTEEL 167.67 -4.66 (-2.7%) | TCS 2530.00 23.10 (0.92%) | TECHM 1790.00 -39.10 (-2.14%) | TITAN 4299.70 -50.30 (-1.16%) | TMPV 264.60 -5.40 (-2%) | TRENT 2727.50 -48.30 (-1.74%) | ULTRACEMCO 11050.00 92.00 (0.84%) | WIPRO 189.84 -0.57 (-0.3%) |
Top